Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

(Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N'-(pyrazin-2-yl)acrylohydrazide

EU orphan designation number: EU/3/14/1313   
Active ingredient: (Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N'-(pyrazin-2-yl)acrylohydrazide
Indication: Treatment of acute myeloid leukaemia
Sponsor: Karyopharm Europe GmbH
Franziska-Bilek-Weg 9, 80339 München, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
26/08/2014 Orphan designation EMA/OD/061/14 (2014)6119 of 22/08/2014
12/08/2015 Transfer of orphan designation EMA/OD/061/14/T/01 (2015)5786 of 10/08/2015